GSK Daprodustat bags USFDA review to treat anemia of CKD Ruchika Sharma20 April 2022 11:44 AM ISTDaprodustat, a HIF-PHI, belongs to a novel class of oral medicines indicated for the potential treatment of anemia of CKD in adult patients not on...
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 11:17 AM ISTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
USFDA amends emergency use authorization for Sotrovimab due to Omicron BA.2 Subvariant Ruchika Sharma27 March 2022 10:15 AM ISTSan Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that the US Food and Drug Administration (USFDA) has amended...
GSK, Medicago get Health Canada nod for COVIFENZ MD Bureau27 Feb 2022 11:00 AM ISTNew Delhi: Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) have recently announced that Health Canada...
GSK Consumer Healthcare to go independent, called Haleon MD Bureau25 Feb 2022 12:42 PM ISTNew Delhi: GlaxoSmithKline plc (GSK) has announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in...
GSK, MS Dhoni join hands for 6 in 1 vaccination awareness campaign MD Bureau24 Feb 2022 1:52 PM ISTNew Delhi: GSK has recently announced that the company has teamed up with Mahendra Singh Dhoni to raise awareness about the need for 6 in 1...
GSK, Sanofi to seek regulatory authorization for COVID vaccine MD Bureau24 Feb 2022 11:00 AM ISTParis: Sanofi and GSK have announced that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory...
GSK halts respiratory virus vaccine trial in pregnant women Ruchika Sharma19 Feb 2022 2:16 PM ISTLondon: GSK has paused a late-stage trial of its vaccine candidate against the respiratory syncytial virus (RSV) in pregnant women based on safety...
GSK Pharma net profit falls 3.9 percent to Rs 150.3 crore in Q3 Ruchika Sharma8 Feb 2022 9:30 AM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Monday reported a 3.93 per cent decline in consolidated net profit to Rs 150.35 crore in the third...
Pfizer vaccine executive Phil Dormitzer to join GSK as Global Head of Vaccines RnD Ruchika Sharma1 Dec 2021 12:00 PM ISTUnited Kingdom: Drug maker, GSK, has recently announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3...
GSK Pharma net profit jumps over two-folds to Rs 204 crore in Q3 Ruchika Sharma31 Oct 2021 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) Pharmaceuticals on friday posted an over two-fold increase in its consolidated net profit at Rs 204.24 crore for the...
